Join
Live feed
·
INSIDERFilingvia Quantisnow
TherapeuticsMD Inc. logo

SEC Form 4: Donegan Michael C converted options into 5,940 shares and sold $8,621 worth of shares (1,697 units at $5.08), increasing direct ownership by 56% to 11,853 units to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.
TXMD· TherapeuticsMD Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TXMD (TherapeuticsMD Inc.) and more on Quantisnow.

SEC Form 4: Donegan Michael C converted options into 5,940 shares and sold $8,621 worth of shares (1,697 units at $5.08), increasing direct ownership by 56% to 11,853 units to cover taxes | Quantisnow